![PathwayMD: Revolutionizing Clinical Decision Support with AI Tools](https://oncodaily.com/pub/uploads/2024/07/Roupen-Odabashian-e1720727929820.jpeg)
PathwayMD: Revolutionizing Clinical Decision Support with AI Tools
Roupen Odabashian shared a post by
on LinkedIn:“Clinical decision support _ CDS Review!
I recently had the chance to use PathwayMD in the clinic, and I was impressed by its features.
Beyond helping with clinical decision support and answering questions, it offers tools like calculators, consolidating many I use regularly into one site.
It also simplifies reading clinical trials and studies and keeps physicians updated with recent publications in their field by bringing these trials to their platform.
You should try this tool; it is much faster than reading individual papers or articles to find answers to your clinical questions. ”
Quoting
‘s post:“We recently had the opportunity to explore Pathway MD, a clinical decision support tool designed to help healthcare professionals find quick answers to their clinical questions.
We reviewed its user-interface, access to recent studies, medical calculators, and diagnostic pathways,
it’s a comprehensive resource for physicians. For a deeper dive, check out the video review here.
Timestamps from our review:
00:00 Introduction
01:00 user interface
02:23 Consistency and Comprehensiveness
06:00 Up To Date Information
08:13 Diseases
10:08 Studies
11:59 Pathways
12:58 Calculator
14:53 Drugs Specialties Findings.”
Source: Roupen Odabashian/LinkedIn and /LinkedIn
Dr. Roupen Odabashian is an accomplished Internal Medicine Physician and Hematology/Oncology Fellow with a profound commitment to advancing healthcare through clinical practice, research, and technology. Currently based at the prestigious Karmanos Cancer Institute, Dr. Odabashian is actively involved in pioneering cancer treatments and conducting clinical research.
In addition to his clinical work, Dr. Odabashian is a multifaceted healthcare professional. He hosts podcast at OncoDaily, engaging with leading experts in oncology to share valuable insights with the medical community. Dr. Odabashian also contributes his expertise as an advisor at Spiraldot Health and Mesh AI, supporting innovative ventures in healthcare technology and collaborative scheduling to combat clinician burnout. With his diverse roles and unwavering dedication, Dr. Odabashian exemplifies a commitment to driving positive change in healthcare.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023